Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cara Therapeutics (CARA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 858,914
  • Shares Outstanding, K 32,510
  • Annual Sales, $ 90 K
  • Annual Income, $ -57,280 K
  • 36-Month Beta 3.16
  • Price/Sales 9,604.68
  • Price/Cash Flow 0.00
  • Price/Book 27.57

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.92 +69.28%
on 05/31/17
28.50 -5.44%
on 06/27/17
+10.24 (+61.28%)
since 05/26/17
3-Month
14.15 +90.46%
on 05/05/17
28.50 -5.44%
on 06/27/17
+7.86 (+41.17%)
since 03/28/17
52-Week
4.72 +470.97%
on 06/29/16
28.50 -5.44%
on 06/27/17
+22.16 (+462.63%)
since 06/28/16

Most Recent Stories

More News
Today's Research Reports on Trending Tickers: AVEO Pharmaceuticals and Cara Therapeutics

NEW YORK, NY / ACCESSWIRE / June 28, 2017 / U.S. markets continued to slide Tuesday as a vote on health care legislation was delayed by Republicans in the Senate and losses by the technology sector deepened....

AVEO : 2.27 (+8.61%)
CARA : 26.95 (+2.01%)
Cara Therapeutic Up 59.8% Since SmarTrend Uptrend Call (CARA)

SmarTrend identified an Uptrend for Cara Therapeutic (NASDAQ:CARA) on May 15th, 2017 at $17.15. In approximately 1 month, Cara Therapeutic has returned 59.81% as of today's recent price of $27.40.

CARA : 26.95 (+2.01%)
Today's stock options reports include trade ideas for Cara Therapeutics, Chemours Co, Dunkin' Brands, Trade Desk Inc and United Parcel Service

InvestorsObserver issues critical PriceWatch Alerts for CARA, CC, DNKN, TTD, and UPS.

CC : 36.63 (+4.39%)
CARA : 26.95 (+2.01%)
TTD : 52.54 (+4.02%)
UPS : 110.08 (+0.37%)
DNKN : 54.81 (+0.31%)
Cara Therapeutics (CARA) Shows Strength: Stock Adds 12.2 % in Session

Cara Therapeutics, Inc. (CARA) was a big mover last session, as the company saw its shares rise over 12% on the day

CARA : 26.95 (+2.01%)
EXEL : 24.02 (+1.82%)
SmarTrend Watching for Potential Pullback in Shares of Cara Therapeutic After 8.96% Gain

Cara Therapeutic (NASDAQ:CARA) traded in a range yesterday that spanned from a low of $22.91 to a high of $25.15. Yesterday, the shares gained 9.0%, which took the trading range above the 3-day high...

CARA : 26.95 (+2.01%)
Biotech Stocks Showing Signs of Resurgence

PALM BEACH, Florida, June 26, 2017 /PRNewswire/ --

AVEO : 2.27 (+8.61%)
CARA : 26.95 (+2.01%)
PTLA : 55.42 (+1.86%)
JUNO : 31.36 (+6.88%)
MBRX : 3.28 (+65.66%)
Biotech Stocks Showing Signs of Resurgence

The Nasdaq Biotechnology Index (NBI) surged last week as Research and Development for the advancement of rare cancer therapies and anti-cancer drug candidates heat up with new partnerships with Mayo Clinic...

AVEO : 2.27 (+8.61%)
CARA : 26.95 (+2.01%)
PTLA : 55.42 (+1.86%)
JUNO : 31.36 (+6.88%)
MBRX : 3.28 (+65.66%)
Implied Volatility Surging for Cara Therapeutics (CARA) Stock Options

Investors in Cara Therapeutics (CARA) need to pay close attention to the stock based on moves in the options market lately.

CARA : 26.95 (+2.01%)
Cara Receives Breakthrough Therapy Designation from FDA for I.V. CR845 for the Treatment of Chronic Kidney Disease-Associated Pruritus in Hemodialysis Patients

Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral...

CARA : 26.95 (+2.01%)
Cara Therapeutic Set to Possibly Pullback After Yesterday's Rally of 4.31%

Cara Therapeutic (NASDAQ:CARA) traded in a range yesterday that spanned from a low of $19.12 to a high of $20.85. Yesterday, the shares gained 4.3%, which took the trading range above the 3-day high...

CARA : 26.95 (+2.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is in the Top 1%. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics, Inc. is based in Shelton, United States.

See More

Support & Resistance

2nd Resistance Point 29.95
1st Resistance Point 28.45
Last Price 26.95
1st Support Level 25.05
2nd Support Level 23.15

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.